Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
Mar 31, 2021

Sanofi announces investment of approximately $925 million (CAD) to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines in Canada, the United States, and

Mar 22, 2021

The certification recognizes the outstanding commitments and actions of companies to achieve gender parity at all levels of business. Sanofi was the first global biopharmaceutical company with a...

Feb 23, 2021

DUPIXENT® is the only biologic medicine approved to treat atopic dermatitis for this patient population. Fifth indication for DUPIXENT® in Canada following approvals for moderate-to-severe...

More »

Stay Updated
* Required Fields